Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2012; 4(02): 127
DOI: 10.4103/0974-2727.105595
Letters to Editor

An Improved NAT Assay with Enhanced Sensitivity for HBV for Donor Blood Screening

Kabita Chatterjee
Department of Transfusion Medicine, All India Institute of Medical Sciences, Main Blood Bank, Ansari Nagar, New Delhi- 110 029, India
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints


Publication History

Article published online:
09 May 2020

© 2012.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • REFERENCES

  • 1 Panda M, Kar K. HIV, hepatitis B and C infection status of the blood donors in a blood bank of a tertiary health care centre of Orissa. Indian J Public Health 2008;52:43-4.
  • 2 Mahtab MA, Rahman S, Khan M, Karim F. Hepatitis B virus genotypes: An overview. Hepatobiliary Pancreat Dis Int 2008;7:457-64.
  • 3 Abraham P, Radhakrishnan S, Raghuraman S, Viswanathan T, Daniel D, Sitaram U, et al. GB virus-C/hepatitis G virus and transfusion-transmitted virus infection in blood donors in a tertiary care hospital in south India. Vox Sang 2001;81:264-5.
  • 4 Candotti D, Grabarczyk P, Ghiazza P, Roig R, Casamitjana N, Ludicone P, et al. Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol 2008;49:537-47.
  • 5 Louisirirotchanakul S, Oota S, Khuponsarb K, Chalermchan W, Phikulsod S, Chongkolwatana V, et al. Occult hepatitis B virus infection in Thai blood donors. Transfusion 2011;51:1532-40.
  • 6 Lin C, Margiritis A, Heaton W, Linnen J. Evaluation of the Procleix Ultrio Plus Assay-A Second Generation Multiplexed NAT Assay for HIV-1, HCV and HBV. Vox Sang 2008;95(Suppl 1 P667):303.